The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The drug is called Journavx and doctors believe it has no potential for addiction and dependence.

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

The FDA just approved a new pain medication called Journavx, which promises to treat pain without the risk of developing an addiction. 21 News is joined by Dr. Jianguo Cheng with the Cleveland Clinic ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.